Sh2d7
-
Official Full Name
SH2 domain containing 7
| Cat.# | Product name | Source (Host) | Species | Tag | Protein Length | Price |
|---|---|---|---|---|---|---|
| SH2D7-15061M | Recombinant Mouse SH2D7 Protein | Mammalian Cell | Mouse | His |
|
|
| SH2D7-1335H | Recombinant Human SH2D7 Protein, MYC/DDK-tagged | HEK293 | Human | Myc&DDK |
|
|
| Sh2d7-5837M | Recombinant Mouse Sh2d7 Protein, Myc/DDK-tagged | HEK293T | Mouse | Myc&DDK |
|
|
| SH2D7-8119M | Recombinant Mouse SH2D7 Protein, His (Fc)-Avi-tagged | HEK293 | Mouse | His&Fc&Avi |
|
|
| SH2D7-8119M-B | Recombinant Mouse SH2D7 Protein Pre-coupled Magnetic Beads | HEK293 | Mouse |
|
Involved Pathway
Sh2d7 involved in several pathways and played different roles in them. We selected most pathways Sh2d7 participated on our site, such as , which may be useful for your reference. Also, other proteins which involved in the same pathway with Sh2d7 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
| Pathway Name | Pathway Related Protein |
|---|
Protein Function
Sh2d7 has several biochemical functions, for example, molecular_function. Some of the functions are cooperated with other proteins, some of the functions could acted by Sh2d7 itself. We selected most functions Sh2d7 had, and list some proteins which have the same functions with Sh2d7. You can find most of the proteins on our site.
| Function | Related Protein |
|---|---|
| molecular_function | CDV3,FAM167AB,DEFB7,MPPED1,AGPHD1,LRRC38,MSLNL,CRYGM5,WNK2,FAM117AB |
Interacting Protein
Sh2d7 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with Sh2d7 here. Most of them are supplied by our site. Hope this information will be useful for your research of Sh2d7.
Resources
Related Services
Related Products
References
- Nadler, Y; Gonzalez, AM; et al. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. ANNALS OF ONCOLOGY 21:466-473(2010).
- Pearson, D; O'Donnell, RT; et al. CD22-binding peptides derived from anti-CD22 ligand blocking antibodies retain the targeting and cell killing properties of the parent antibodies and may serve as a drug delivery vehicle. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS 14:237-246(2008).
